Aytu BioPharma launches depression drug EXXUA in U.S. market
DENVER- Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…






